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CattleMouse Elf5 is expressed exclusively in the trophectoderm from the late blastocyst stage to postgastrulation.
We demonstrate here that the proximal promoter is used for trophectoderm expression but is not sufﬁcient
on its own. In transgenic assays, deletion of a differentially methylated region (DMR) within the promoter
has no effect on the activation and maintenance of trophectoderm expression and does not result in ectopic
activity. Two redundant enhancers drive Elf5 expression to the extraembryonic ectoderm and ectoplacental
cone. The enhancers, located in the 5′ half of intron 1 and 3′ half of intron 2, require the presence of 1.8 kbp,
although not the DMR, of the endogenous proximal promoter for optimal activity. These trophectoderm
enhancers are mouse speciﬁc. A cattle Elf5 BAC reporter transgene is not expressed in mouse trophectoderm
although it is expressed in skin, a known foetal domain of mouse Elf5 expression. The established importance
of Elf5 for mouse trophectoderm at pre- and perigastrulation stages is not a conserved mammalian feature as
Elf5 expression localises to embryonic as opposed to trophectodermal ectoderm in cattle.
© 2011 Elsevier Inc. All rights reserved.Introduction
The ﬁrst lineage decision of the mammalian embryo is that be-
tween trophectoderm and the inner cell mass, with trophectoderm
cells restricted in their fate to the foetal component of the future pla-
centa (Berg et al., 2011; Suwinska et al., 2008). In mice, the trophec-
toderm cells overlying the inner cell mass of the blastocyst stage
embryo are termed the polar trophectoderm and it is these cells
that maintain a proliferative undifferentiated state, giving rise to
both the extraembryonic ectoderm (ExE) and the overlying ectopla-
cental cone (EPC) cells at egg cylinder stages (Gardner, 1985;
Simmons and Cross, 2005). During gastrulation, the ExE is displaced
proximally (away from the embryo proper) by the extraembryonic
mesoderm lining the expanding exocoelic cavity. The ExE eventually
forms the chorion and then the syncytiotrophoblast cells of the
inner labyrinth of the placenta. The ectoplacental cone gives rise to
the spongiotrophoblast cells which make up the stromal layers of
the placenta. Trophoblast stem (TS) cells can be derived from blasto-
cyst to gastrulation stage embryos (Tanaka et al., 1998; Uy et al.,
2002). These cells are most similar to ExE tissue in terms of marker
gene expression and present a useful in vitro model for trophecto-
derm differentiation studies (Tanaka et al., 1998).
The transcription factor Elf5 is essential to ExE maintenance in
mice as loss of function mutants result in the ablation of the ExE,
resulting in the embryonic ectoderm directly adjoining an EPC-like
layer of trophectoderm (Donnison et al., 2005). In Elf5 mutantPfeffer).
rights reserved.embryos the continued presence of trophoblast in the form of ecto-
placental cone and giant cells argues against a role of Elf5 in the initial
speciﬁcation of trophectoderm. No TS cells can be isolated from Elf5
deﬁcient embryos, indicating a speciﬁc function for Elf5 in maintain-
ing a population of proliferative, diploid undifferentiated trophoblast
progenitor cells (Donnison et al., 2005). The observation that a 1 kbp
region upstream of Elf5 is hypermethylated in mouse ES cells, which
do not express Elf5, and hypomethylated in TS cells, which do, has
led to the hypothesis that Elf5 is a gatekeeper for enforcing the tro-
phectoderm lineage (Ng et al., 2008). Global demethylation in ES
cells grown in TS cell medium leads to Elf5 hypomethylation and tran-
scriptional activation, as well as increased appearances of giant cells.
The authors proposed that the hypomethylation of Elf5 is the causal
trigger for Elf5 transcriptional activation with Elf5 activating the tro-
phoblast lineage-determining factors Cdx2 and Eomesodermin,
which in turn feedback on Elf5 to maintain its expression. This posi-
tive feedback loop would thus lock cells into a trophoblast fate (Ng
et al., 2008). Whether this demethylation trigger and Cdx2 activation
role of Elf5 are also important in vivo is less clear as Cdx2 is expressed
before Elf5 (Donnison et al., 2005).
In view of the central role of Elf5 to the trophoblast lineage, an
analysis of its regulation is important. Elf5 belongs to the superfamily
of Ets transcription factors characterised by sharing a highly con-
served DNA binding domain (Hollenhorst et al., 2011). Structurally
Elf5 is most similar to the Elf/EPS subfamily, which all contain a N-
terminal pointed domain and closely related C-terminal winged-
helix DNA binding domains (Sharrocks, 2001). Members of this sub-
family are predominantly expressed in secretory/glandular epithelia
at foetal and adult stages. Elf5 is expressed in the salivary gland, kid-
ney, lung, stomach (Lapinskas et al., 2004; Metzger et al., 2008), the
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(Choi et al., 2008) and is critical for alveolar development in mamma-
ry glands (Oakes et al., 2008). During embryonic stages, Elf5 is exclu-
sively expressed in the trophectoderm lineage, predominantly in the
ExE and its derivatives, and mouse mutants can be rescued by tetra-
ploid complementation (Donnison et al., 2005). While low levels of
Elf5 have been detected during early development in another mam-
mal, namely cattle, the spatial localisation has not been deﬁned
(Smith et al., 2010). In mice, Elf5 is located on chromosome 2, consist-
ing of 7 exons spread over 27 kbp. The closely related Ehf/Elf3 gene is
located 120 kbp upstream of Elf5 in the opposite orientation but is not
expressed in trophectoderm (M.D, P.L.P, unpublished observation).
We aimed here to delineate the mouse chromosomal regulatory re-
gions required for Elf5 expression in the trophectoderm using an in
vivo approach of generating transgenic embryos. Our results demon-
strated redundancy in Elf5 trophectoderm regulatory elements and
suggest that this regulation is not conserved among mammals.
Materials and methods
Construct generation
Elf5 coordinates for all constructs are shown in Table 3. Inserts for
constructs (#) 1, 3, 5, 7, 11 and 20 were generated by restriction di-
gestion of Elf5 genomic clones derived from a 129 mouse λ library
(Stratagene) or via PCR (template: 10 ng of Elf5-BAC) adding appro-
priate restriction sites and inserted into the equivalent sites upstream
of the minimal β-globin promoter of pTrap (Pfeffer et al., 2000). For
constructs 4, 6, 12, 17, 19, and 21–24 the 1.8 kbp promoter fragment
upstream of exon 1A was initially cloned into pTrap to generate
pProm-Trap. Construct 9 was a 19 kbp ClaI fragment from #8 (the
modiﬁed Elf5-BAC), subcloned into pBSII. Construct 13 was generated
by subcloning the 5′ClaI, 3′SnaBI fragment of #9 into ClaI/EcoRV re-
stricted pBSII. Construct 16 was generated from #9 via recombineer-
ing (see below), retaining the ﬁrst 40 bp and 3′-most 31 bp of
intron1 and inserting a loxP site ﬂanked by MluI (5′) and AscI (3′)
sites. Construct 2 was derived from #16, as #13 was from #9. Con-
structs 14 and 15 were generated by inserting PCR fragments contain-
ing 5′MluI and 3′ AscI ends into #16. Construct 18 was a subclone of
#16 made by inserting the large ClaI/SwaI fragment into ClaI/EcoRV
digested pBSII.
Constructs 8, 10, 16, 25 and bElf5-BAC were created by ET-based
homologous recombination (recombineering) technologies. For con-
struct 8, a building vector was made by inserting 49 bp exon 2 Elf5 se-
quence [64–112 (numbering relative to ATG)] into the BamHI/NsiI
sites downstream of the frt of pSP-polyA-frt-neo-frt (kindly donated
by Dr. Busslinger). The upstream 50 bp Elf5 homology box [−50 to
+1] followed by NcoI-eGFP was PCR-ampliﬁed from a pEGFP-N1
(Clontech) template and inserted into XhoI/EcoRI sites 5′ to the SV40
polyA. Recombination (Muyrers et al., 1999) with mouse Elf5 BAC
RP23-44A14 (C57Bl/6J strain; CHORI) resulted in the insertion of the
GFP-polyA-frt-neo-frt cassette 7 bp downstream of the splice acceptor
junction of Elf5 exon2, thereby removing 62 bp Elf5 exon2 sequence
including the endogenous Elf5 start codon. Constructs were veriﬁed
by restriction mapping and sequencing of the modiﬁed regions. The
neo gene was removed by Flp-mediated recombination (Liu et al.,
2003) before generating derivative constructs. Constructs 10 and 16
were derived from #9 using the Copeland lab protocol (Liu et al.,
2003) and pL452, which contains a loxP-ﬂanked neo gene. Homology
boxes (300–500 bp) ﬂanking the regions to be deleted were generat-
ed by PCR adding unique restriction sites (SalI/EcoRI and BamHI/NotI
respectively) and ligated into pL453 in two steps. These constructs
were used for ET-recombination in SW102 [λc1857] cells previously
transfected with #9 as described (Liu et al., 2003). The neo gene
was removed by Cre-mediated recombination using SW106 cells
(Warming et al., 2005). The B-enhancer conserved region deletionof #25 resulted from recombineering #9 to yield #25pre. Intron 1
was subsequently removed by exchanging the conserved-B contain-
ing Asp718 fragment of #16 with that of #25pre. BovineElf5-DsRed-
BAC: A DsRedExpress cassette was inserted 5 bp downstream of the
start of exon 2 in bovine Elf5BAC (CH240_227e23), replacing the
following 63 bp of exon 2 including the ATG. In successive steps,
NheI-Kozak-DsRed-SpeI as well as 332 bp (SacII/XhoI) and 319 bp
(BamHI/NsiI) bElf5 homology boxes were generated by PCR and
inserted into the corresponding sites of pSP-polyA-frt-neo-frt to gen-
erate the building vector used for recombination.
Transgenic embryos
Animal procedures were conducted under the approval of the
Ruakura Animal Ethics Committee (R.A.E.C. 11183). Vector-free line-
arised DNA was injected at 2–3 ng/μL into FVB pronuclei to generate
transgenic mouse embryos. BAC DNA was puriﬁed on QIAGEN-500
columns followed by CsCl/EtBr gradient ultracentrifugation. The
supercoiled DNA was extracted with isoamyl-alcohol and extensively
dialyzed (3 days) against 10 mM Tris pH 7.5, 0.1 mM EDTA (T0.1E)
prior to pronuclear injection at 1 ng/µL in T0.1E, 30 μM spermine,
70 μM spermidine, 100 mM NaCl. Transgenic embryos/animals were
identiﬁed by PCR with the lacZ primers 5′-ATACTGTCGT-
CGTCCCCTCA-AACTG-3′ and 5′-TTCAACCACC-GCACGATAGA-GATTC-
3′ or GFP primers 5′-CCGACCACAT-GAAGCAGCAC-GAC-3′ and 5′-
TCACGAACTC-CAGCAGGACC-AT-3′. For embryos, genotyping was
performed on the whole embryo after the staining reaction. Trans-
genic lines refer to either transient transgenic lines (embryos recov-
ered directly) or established mouse lines. The respective numbers of
each are shown in Table 3.
β-Galactosidase staining, GFP visualisation and in situ hybridisation
X-gal staining was performed for 1–72 h as described (Pfeffer
et al., 2000). Some embryos were washed after post-ﬁxation in 50%
glycerol/PBS and cleared in 80% glycerol/PBS prior to photography.
Expression of ﬂuorescent proteins was detected using either Leica
DMIRB and DMI6000B inverted microscopes with N2.1/GFP ﬁlter
sets (no ﬁxation of embryos) or an Olympus FV1000 confocal micro-
scope. Whole mount in situ hybridisation (WMISH) was performed as
described (Donnison et al., 2005) using a full length eGFP Dig-labelled
antisense probe.
Chromatin immunoprecipitation
Two million TS cells or TS cells allowed to differentiate for seven
days by removal of FGF4/heparin and conditioned medium, or
mouse R1 ES cells were used per 2 μg of antibody to Histone H3-
mono methyl K4 (Abcam, ab8895) or tri methyl K4 (AbCam,
ab8580) for chromatin immunoprecipitation (ChIP), following the
protocol of Nelson and co-workers (Nelson et al., 2009). Primers are
listed in Table 1.
PCR
For promoter usage analysis, RNA from feeder-free TS cells and a
pool of E6.5 ExE manually dissected away from the epiblast (but
retaining the hypoblast) was isolated using Trizol and reverse tran-
scribed (Smith et al., 2010). For Elf5 transcription in samples shown
in Fig. 3A, cells were prepared as described under Chromatin immuno-
precipitation. Cattle E11 embryos were manually dissected into “TE”
(approximately two thirds of the embryo containing TE and underly-
ing hypoblast) and “Epiblast-enriched” (one third containing the epi-
blast, trophoblast and the underlying hypoblast).
We quantiﬁed transcripts relative to mouse or cattle (as relevant)
GAPDH housekeeper (HK) while normalising for different
Table 1
Primers used for real-time PCR analysis of ChIP-DNA.
Name Forward (5′ to 3′) Reverse (5′ to 3′)
Elf5:-670 AGAGTGGAAAGGCCAGTGAA AATCTGTCCTTGGGTTGCTG
Elf5:-330 TACAGAGGTTCGGGACTTGG GACCCAGGAAATGAGCAGAG
Elf5:-279 ACCAGGCCTGAATTTCCTTC CCTTTCTCCTGCTTTTGTGC
Elf5:1131 AAATCCTCAGGACGCTCAGCGG TCTGACTTTCTTGCAGGCGTGC
Elf5:2042 GAGGATCTCGGCTCGGGTCA AAGCTCACATACCACGCAGA
Elf5:3011 AGCTGTGCAAACCCAGACCTGG GGCCTTGGAAGGTGCTTGCAA
Elf5:4142 CATGCAGTTCTTCTGCACACCG GCTGGAGGGAGGCCCTAAGT
Elf5:5151 AAGCTGAGGTTAGCGGGCACAA GGCAGCTCAGGTGGATCAGCTT
Elf5:6190 ACAGCCCCTCTGATATTCCA GATGCTCAAAGGCAGGGTAG
Elf5:7215 CCGCAGTCCACGTGCAGTGAA TGACATGGCATTGTCAGCTGCA
Elf5:8775 GACAAGTGACGGCTGAGAGG CCTGCTTCAAAGAGCAGTCC
Elf5:10671 TCCCGGTCCAGTTTCTTATG ATGAGGGAAGTCCTGTGGTG
Elf5:12519 AACAGCTTCCTGGTGCCATA TTGACATTCTTTGGCTGCTG
A B
Fig. 1. Elf5 promoters do not lead to ExE expression. (A) The Elf5 locus is depicted at
the top with sequence conservation to the human gene. Conservation was determined
using the ECR browser ((Ovcharenko et al., 2004), http://ecrbrowser.dcode.org;
50–100% scale; red, intergenic; yellow UTRs; blue, exonic; salmon, intronic; green, sim-
ple repeats; white: below 70% identity over 100 bp window). Below are construct de-
sign and number of independent embryo/lines (tg), number of transgenic embryos
positive in the ExE or showing ectopic expression (Ect; non-Elf5-like). Promoter se-
quences upstream of exon 1A or 1, or both, linked to the minimal promoter of pTRAP
did not result in ExE expression at E6.5 or 7.5. Construct #2 simulated the endogenous
Elf5 gene structure with 4 kbp of sequence upstream of exon 1 and GFP following the
splice acceptor of exon 2. No ﬂuorescence was seen. Ect, ectopic expression detected
as indicated; C,ClaI; H, HindIII. (B) Promoter usage as determined by real-time RT-PCR
using exon 1A, 1 and 2 primers. Expression levels normalised to exon 1. mTS, mouse
trophoblast stem cells; ExE dissected from E6.5 embryos.
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terest (goi)=[agoi^(−Ctgoi)] / [aHK^(−CtHK)], where Ct represents
the number of cycles required to reach a constant threshold level of
ﬂuorescence and the term ax^(−Ctx) is equal to the starting concen-
tration of gene X (which is the variable to be measured), times a con-
stant that depends on the threshold level (Smith et al., 2007). Each
sample was measured in triplicate, one measurement being of a two-
fold dilution. Samples not showing halving of copy number ±50%
when diluted twofold were deemed to lie outside the linear range
and discarded. A no template control, RT- control and dissociation
curve analysis were included in each real-time run. Real time PCR
was done on a Corbett Rotorgene 6000 (Qiagen) with SYBR ExTaq
Mix (Takara) using 3 min initial denaturation, followed by 40 cycles
of 95 °C for 10 s, 60 °C for 25 s. Primers are listed in Table 2.
Results
The role of the Elf5 promoters in ExE expression
Two alternate promoters exist for Elf5 leading to two variant tran-
scripts differing in the 5′ untranslated regions by virtue of alternate
ﬁrst exons being spliced to the common exon 2 (Fig. 1A). The proxi-
mal promoter upstream of exon 1 is located 6.2 kbp upstream of the
translational start of Elf5 that is located within exon 2 (reference se-
quence NM_010125). The distal promoter is a further 12.4 kbp up-
stream, driving transcription from exon 1A (A for alternate;Table 2
Primers used for RT-PCR analyses.
Region Forward (5′ to 3′) Reverse (5′ to 3′)
Promoter usage
Elf5 exon 1Aa GTCACAGGTAGCACGCTCAG TGTAGCAGGGTCCTGGAATG
Elf5 exon
1A to 2a
CAACCTGGCGGGACAAATGAA GATGCTCAAAGGCAGGGTAG
Elf5 exon 1
to 2
ACGGCTACAGGTGCCTTTATT GATGCTCAAAGGCAGGGTAG
Elf5 exon 1 ACGGCTACAGGTGCCTTTATT ACAAGTGGTGGCTAGGTCCA
ES/TS/diff TE
Elf5 TCAAGACTGTCACAGCCGAACAA GCGCGTTCTTTCCAAATTTGTA
Gapdh TGCACCACCAACTGCTTAG GATGCAGGGATGATGTTC
BAC constructs
GFP CCGACCACATGAAGCAGCACGAC TCACGAACTCCAGCAGGACCAT
DsRed/bovElf5 TTGTCTCAACCTCTCTGCCTC AGCCCTCCATGCGCACCTTGA
Cattle E11
bovElf5 TAAATCAGAAGCCCTGGCGAAGA ACATGAGCTGGATGATGGAGCA
bovGapdh CTCCCAACGT GTCTGTTGTG TGAGCTTGAC AAAGTGGTCG
a The exon 1A primers measure abundance of longer version of exon 1A (Ensem-
blENSMUST00000137973) while exon 1A to 2 forward primer is at 3′ end of exon 1A
and thus detects all 1A-containing versions (including the short NM_001145813).NM_001145813). We quantiﬁed the usage of these promoters in
E6.5 extraembryonic ectoderm and in trophoblast stem cells by real
time RT-PCR (Fig. 1B). Primer pairs were designed within the respec-
tive exons 1 and between exon 1 or 1A and exon 2. Both tissues dis-
played exclusive usage of the proximal Elf5 promoter with exon 1A-
containing transcripts not detectable above background levels.
We tested the extended proximal promoter region for enhancer
activity using the pTrap vector consisting of a multiple cloning site
upstream of a minimal β-globin promoter and the lacZ reporter.
Four kilobasepair (kbp) of sequence immediately upstream of exon
1, including the proximal promoter, were inserted into pTrap and
transgenic embryos generated. No reporter gene expression in the
ExE was detected (construct #1). In one such transgenic line ectopic
expression was seen in various tissues at later stages (E8.5, E13.5) in-
dicating that the construct had the potential of being expressed if it
had contained an ExE-enhancer. We built a similar but more endoge-
nous reporter construct by deleting intron 1 and splicing GFP in frame
into exon 2, three amino acids downstream of the Elf5 translational
start site (#2). No trophectoderm (ExE) expression was seen in 12 in-
dividual lines.
The high mouse to human sequence conservation of the region
surrounding alternate exon 1a (Fig. 1A histogram) suggested the po-
tential existence of an evolutionary-conserved regulatory element
here. However, neither this region linked to the minimal promoter
of pTrap nor joined to 1.8 kbp of the Elf5 proximal promoter led to
ExE expression (#3, 4). Permanent lines exhibited non-consistent ec-
topic expression at later stages, presumably owing to integration near
strong enhancers.
We conclude that while the proximal promoter drives Elf5 expres-
sion in trophectoderm tissues, it is not sufﬁcient on its own.
Transgenic constructs mimicking Elf5 expression
Enhancers are often localised upstream of the transcriptional start
site in regions displaying high sequence conservations. To this end we
constructed reporter #5, encompassing 4.2 kbp of sequence from
27 kbp upstream of Exon 1 which showed high evolutionary conser-
vation (Fig. 2A). However, neither this area nor the region between
exons 1a and 1 (#7) exhibited ExE-enhancer activity. Recently,
ChIP-seq data from the lab of Ko (Nishiyama et al., 2009) suggested
the existence of functional Cdx2 binding sites involved in Elf5 upregu-
lation 18 kbp upstream of exon 1. However, the region containing
DA
B C E F
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Fig. 2. Evolutionary conserved regions upstream of Elf5 including the differentially
methylated region are dispensable for robust Elf5 expression. (A) Constructs 5–7,
encompassing regions of high sequence conservation (#5), proposed as having Cdx2-
dependent enhancer activity (#6) or encompassing the regions between promoters
1A and 1 (#7) were not sufﬁcient for ExE-speciﬁc expression. In-frame splicing of
GFP after the second amino acid of Elf5 in exon2 in the context of a 120 kbp BAC
(#8) resulted in an Elf5 expression pattern as seen by ﬂuorescence (B, C) and whole
mount in situ hybridisation using a GFP antisense probe (D). (E) This pattern was
also evident in a 19 kbp ClaI fragment. Confocal image of E6.5 transgenic embryo;
note that the Kan-resistant cassette was ﬂipped out. (F–H) Removal of the DMR region
(#10) did not lead to ectopic expression in the ICM at blastocyst stages or in regions
outside the trophectoderm at later stages. The embryos transgenic for constructs 10
are from separate lines, with G and H being ‘transient’ (G0) transgenics. Dotted box,
SV40-polyA signal; black triangle; frt-site; [xxx], bp relative to exon 1 start; ExE, extra-
embryonic ectoderm.
B
C
A
Fig. 3. Histone H3 lysine 4 methylation at the Elf5 locus. (A) Expression of Elf5 in ES, TS
and TS cells after removal of FGF and conditioned medium for 7 days (diff TE), as deter-
mine using quantitative real-time RT-PCR. (B) Histone H3 lysine 4 trimethylation and
(C) monomethylation as percentage of input, as measured by real-time PCR after
ChIP (4, 3 and 1 repeats respectively for TS cells, diff TE and ES cells).
346 D.J. Pearton et al. / Developmental Biology 360 (2011) 343–350these sites could not direct ExE-speciﬁc expression even in conjunc-
tion with the proximal promoter (#6).
As the candidate region approach had been unsuccessful, we de-
termined the wider boundaries within which to search for enhancers
by using BAC technology. An 120 kbp Elf5 BAC extending 70 kbp up-
stream of Elf5 and 23 kbp past the 27 kbp-large Elf5 locus (exons
1–7) was modiﬁed by recombineering technology to insert a GFP-
polyA cassette as well as the kanamycin selection marker at the
start of the Elf5 coding sequence in exon 2 (#8). Transgenic embryos
recapitulated endogenous Elf5 TE expression at all stages examined
(E5 to 7.5; Figs. 2B, C). We examined whether the stability of GFP pro-
tein resulted in a broadening/misrepresentation of the transcriptional
expression domain by performing in situ hybridisation. No differ-
ences were seen (Figs. 2 C, D) indicating that the GFP ﬂuorescence
faithfully represented the region of active transcription.
A 19 kbp fragment derived from the modiﬁed BAC resulted in
transgenic embryos showing strong ﬂuorescence in the ExE (#9).
Confocal analysis revealed that GFP expression was not equally strong
in all ExE cells (Fig. 2E). No ﬂuorescence was seen at mid-blastocyst
stages (not shown) whereas in late, expanded blastocysts expression
was observable in both polar and mural trophectoderm (Fig. 2F).The proximal promoter region (972 to 261 bp upstream of exon 1)
of Elf5 has been shown to bemethylated in ES and unmethylated in TS
cells (Ng et al., 2008). Differential methylation of Elf5 was suggested
to underlie the observed ectopic differentiation of hypomethylated
Dnmt1−/− embryos into trophectoderm cells (Ng et al., 2008). We
removed this 14 CpG-containing, differentially methylated region
(DMR) in the context of the 19 kbp Elf5 fragment (#10). Trophecto-
derm expression was indistinguishable from the parental construct
between blastocyst and gastrulation stages. No ectopic GFP expres-
sion was seen at any stage (Figs. 2F–H). We conclude that if DNA de-
methylation at the DMR is a necessary causal trigger for Elf5
activation, this mechanism is redundant as it can be bypassed (by de-
letion of the DMR) without affecting Elf5 expression.
Epigenetic state of Elf5 locus
Promoters and enhancers are frequently characterised by distinct
epigenetic signatures. In particular, histone H3 lysine 4 tri-
methylation is high around promoters and histone H3 lysine 4
mono-methylation is high in enhancers of genes that are actively
transcribed (Barski et al., 2007; Heintzman et al., 2007). To pinpoint
potential enhancers within the 19 kbp Elf5 fragment, we performed
chromatin immunoprecipitation coupled to real-time PCR (ChIP-
PCR) on three types of cells. TS cells, which highly transcribe Elf5
(Fig. 3A), were used to approximate ExE tissue under the assumption
that the Elf5-ExE enhancers would be active. TS cells allowed to differ-
entiate for 7 days downregulate Elf5, thus representing a recently in-
active or subdued enhancer state. In ES cells the Elf5 locus has been
2 kb
1 2
# tg ExEXSC CH
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B
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peak in H3K4me3 around the Elf5 proximal promoter in TS cells
(Fig. 3B). This peak was reduced in the differentiated cells and absent
in ES cells, conﬁrming that the epigenetic signature at the promoter
correlates with the transcriptional state. The H3K4me3 state of the re-
mainder of the examined locus did not differ in TS and ES cells.
A modestly elevated level of H3K4 monomethylation was ob-
served downstream of the promoter region speciﬁcally in TS cells
(Fig. 3C). Such a broad elevation of H3K4me1 is characteristically
seen in intragenic regions of actively transcribed genes (Barski et al.,
2007). However no distinct sharp peaks of H3K4me1 indicative of dis-
tinct enhancers could be identiﬁed. Thus we could not identify the
ExE enhancer(s) using this epigenetic approach.
An endogenous promoter-dependent ExE-enhancer
The 19 kbp region of the ExE-directing construct 9 was further
analysed. A 7.1 kbp fragment extending from exon 1 to 845 bp be-
yond exon 2 was linked to the minimal β-globin promoter driving
lacZ (#8). No expression was seen in eight transgenic lines. However,
when splicing a 1.8 kbp fragment of the endogenous Elf5 promoter in
between the intron1 fragment and the minimal promoter of pTrap
(#12), mosaic expression in the ExE was seen in one transgenic em-
bryo (Fig. 4B). The requirement for the endogenous promoter regions
was conﬁrmed by removing the intron 2 region from the 19 kbp of
construct 9. This construct (#13) resulted in GFP-ﬂuorescence in the
ExE as well as EPC in all 4 lines (Figs. 4C, D). Robust expression
could be detected as early as E5.5 suggesting that this enhancer par-
ticipates in the onset and maintenance of Elf5 ExE expression. Further
resection (#14, 15) localised the enhancer (termed “A”) to the 5′ half
of intron 1 (Figs. 4A, E). It should be noted that positioning this en-
hancer upstream (#12) versus downstream (#13) of the endogenous
promoter affected the frequency and strength of expression (Figs. 4B–C).B
A
DC E
Fig. 4. The upstream half of intron 1 is sufﬁcient to drive ExE-speciﬁc expression but
only in combination with the endogenous Elf5 promoter. (A) Construct design. (B) In-
tron 1 could direct ExE-speciﬁc β-Gal expression when linked to 1.8 kbp of Elf5 pro-
moter sequences (#12), but not when linked directly to the minimal β-actin
promoter of pTrap (#11; n=8). (C, D) Using 4 kbp of Elf5 promoter 1A sequences
with Intron1 yielded strong expression (#13). (E) The ExE-speciﬁc activity lies in the
upstream half of intron1 (#15). Green box refers to GFP-pA, purple line denotes Elf5
promoter region.It is unclearwhether this reﬂects a context-dependency, or the effect of a
functional intron in #13. Intronic sequences are known to confer beneﬁ-
cial effects on transcription and translation in transgenic constructs
(Fong and Zhou, 2001; Nott et al., 2004).
Redundancy in ExE enhancers
To test whether intron 1 enhancer A is necessary as well as sufﬁ-
cient, we recombineered out intron 1 in the context of the 19 kbp
GFP reporter fragment. Embryos transgenic for this construct (#16)
still exhibited ExE-enhancer activity (Fig. 5D), indicating redundancy
in control regions directing ExE expression. As we had already tested
regions upstream of exon2, this second enhancer had to be located
downstream, but within the 19 kbp, that is, within intron 2. Indeed,
intron 2 directed ExE-speciﬁc expression when placed upstream of
the Elf5 1.8 kbp promoter driving LacZ (#17). However, in this con-
text expression was consistently highly mosaic (Figs. 5B, C). Similar
to enhancer A, this enhancer, (termed “B”), was active from E5.5
(Fig. 5B). Enhancer B was located in the 3′ half of intron 2 (#18,
19). Even in transgenic embryos showing strong expression, β-Gal
staining remained mosaic (Fig. 5E). Importantly, enhancer B, similarly
to enhancer A, was dependent on Elf5 promoter sequences for its ac-
tivity (#20). Further analysis of the 4.3 kbp enhancer B-containing re-
gion (#21–23) indicated that only the central 1.5 kbp sequences
yielded ExE speciﬁc expression (#23). Yet the ability of this minimal
region to direct expression was very poor with only two of 9 lines
exhibiting β-Gal staining and then only in a highly mosaic fashionLacZ
LacZ
LacZ
LacZ
LacZ
LacZ
2x
LacZ
4 417
7 018
6 0
19 4 4
20
9 223
19 021
7 024
16
17
5 525
22 022
23
E6.5
E6.5
E5.5
E6.8
19
E6.5
25
E6.5
C
GFED
Fig. 5. A second enhancer for ExE expression located in the 3′ half of intron 2. (A) Con-
struct summary and statistics of transgenic embryos. Intron 2 could direct ExE-speciﬁc
expression in the endogenous context (#16; D) or when linked to 1.8 kbp of Elf5 pro-
moter sequences (#17; B, C). The lack of EPC expression seen in the embryo depicted
in panel D was not consistent. Enhancer activity resided in the 3′ half of intron 2
(#18, 19; E), and required Elf5 promoter sequences (#20). A minimal region of
1.5 kbp (#23) functioned as a very weak enhancer yielding with only a few β-gal pos-
itive cells (F). A conserved region within the minimal enhancer was neither sufﬁcient
even as two copies (#24) nor necessary (#25, G). Green box refers to GFP-pA. Purple
line denotes Elf5 promoter region. C, ClaI; H, HindIII; S, SnaBI; Sw, SwaI; X, XhoI.
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lies a 480 bp region conserved in eutheran and marsupial mammals
(Fig. S1). We tested whether this conservation was indicative of
ExE-enhancer function in two ways. First, we linked two copies of a
450 bp fragment containing the conserved region, to the Elf5-
promoter (#24). Even with the doubling of this region, no staining
could be detected. Second, we asked whether the conserved region
was necessary for enhancer B activity, so we precisely cut out the
400 bp in the “endogenous” context of intron 2 (#25). GFP-
ﬂuorescence remained strong in the ExE (Fig. 5G). We conclude that
the conserved region within the minimal B enhancer is neither sufﬁ-
cient nor necessary for ExE expression.
Bovine Elf5 BAC
The functional irrelevance to ExE expression of the conserved area
within the minimal B-enhancer implies that the ExE enhancer lies in
sequences that show no readily apparent similarity to more distantly
related mammals (primates, carnivores, ruminants). This could be as-
cribed to two causes. Either the enhancer cannot be identiﬁed by se-
quence comparisons (for example if consisting of a set of conserved
but short protein binding sites with non-conserved spacing) or
other mammals do not have an equivalent enhancer. This latter pos-
sibility is intriguing as it is not clear what constitutes the ExE tissue
in other species. In mice, the ExE is derived from the polar trophecto-
derm overlying the inner cell mass. In ungulates (pigs, sheep, and cat-
tle), carnivores, rabbits, sciurid rodents (squirrels) and insectivores
the polar trophectoderm is termed Rauber's layer once the ICM differ-
entiates into epiblast and hypoblast. Yet before gastrulation com-
mences, Rauber's layer, which could be considered the equivalent of
the ExE, disappears.
We thus tested whether any of the evolutionary conserved regions
within the Elf5 gene locus were marking ExE-enhancers by introduc-
ing a construct bearing cattle Elf5 genomic regions into mouse embry-
os. A DsRed reporter was recombined downstream of the
translational start site in exon 2 in a cattle BAC bearing the entire
Elf5 locus (Table 3). One permanent mouse transgenic line was gener-
ated. We could detect neither ﬂuorescence nor DsRed RNA betweenTable 3
Construct coordinates relative to Elf5 exon 1 start (5′-CACACGGC..) and number of
transient and stable transgenic mouse embryos or lines generated.
Construct (#) Start End Transient
lines
(embryos)
Stable lines
(mouse
founders)
1 −4126 (SalI) +77 (XmnI) 3 1
2 (deletion) +151 +6278 12 0
3, 4 −12,796 −10,226 14 (#3) 0 (#3)
4 (Prom) −1695 (HindIII) +75 (XmnI) 0 (#4) 4 (#4)
5 −27,083 −22,914 12 0
6 −18,037 −17,833 3 0
7 −8701 −2554 7 0
8 −71,675 +49,957 0 2
9 −4163 (ClaI) +14,703 (ClaI) 1 1
10 (deletion) −969 −262 2 1
11, 12 +76 (XmnI) +7180 (SalI) 8, 4 0, 0
13 −4163 (ClaI) +6344 (SnaBI) 6 1
14 (deletion) +151 +2993 3 0
15 (deletion) +3084 +6278 4 0
16 (deletion) +151 +6278 4 0
17 +6922 (XhoI) +14,703 (ClaI) 3 1
18 −4163 (ClaI) +10,373 (SwaI) 7 0
19, 20 +10,374 (SwaI) +14,703 (ClaI) 4, 6 0, 0
21 +10,377 +11,842 19 0
22 +13,182 +14,703 22 0
23 +11,713 +13,234 9 2
24 +12,416 +12,959 7 0
25 (deletion) +12,423 +12,951 5 0
bElf5BAC b−50,000 +48,800 0 1E5.5 and 7.5 (data not shown). Importantly, the cattle Elf5-DsRed
BAC transgene of this line was expressed in other embryonic domains
of Elf5 activity (Figs. 6A, B), proving the functionality of the construct.
The cattle Elf5 locus does show sequence conservation with mouse in
regions within both enhancers A and B. Hence its inactivity in the
mouse suggests that these regions have been conserved for reasons
other than an ExE-enhancer function. Additionally considering the
data showing that the conserved region of the minimal B enhancer
is not required for ExE expression, we conclude that the Elf5 en-
hancers A and B are indeed mouse speciﬁc.
This raised the question as to whether cattle express Elf5 at all in
the trophectoderm. Bovine Elf5 has previously been shown by RT-
PCR to be expressed only around E11 in whole cattle embryos
(Smith et al., 2010). At this stage the cattle embryo resembles a
slightly ovoid large blastocyst with ICM-derived hypoblast (primitive
endoderm) covering the inside surface. The epiblast is still multilay-
ered and covered by Rauber's layer (polar trophectoderm). We per-
formed in situ hybridisation with a bovine Elf5 probe. In stark
contrast to the mouse, expression was restricted nearly exclusively
to the epiblast (Figs. 6C–E). Rauber's layer and the epiblast immedi-
ately below it were devoid of Elf5 expression. This was conﬁrmed by
measuring levels in dissected embryos where the third of the E11 em-
bryo containing the epiblast was enriched for Elf5 transcripts (Elf5 x
1000/Gapdh: Epi-enriched 5.7±1.7 versus TE 4.1±1.0; n=3, P(dif-
ferences)=0.01). Thus Elf5 regulation is diametrically different dur-
ing early development in these two mammals which explains the
lack of evolutionary conservation of the enhancers but also suggests
that placental lineage ontogeny may be very species speciﬁc.
Elf5 expression in the absence of Elf5 function
In Elf5 mutants the ExE but not ectoplacental cone (EPC) is lost
(Donnison et al., 2005). Between E5.5 and E6.5 Elf5 expression can
often be seen to extend into the EPC (Fig. 7A). To determine whether
Elf5 expression in the EPC region was maintained in the absence of
functional Elf5, we crossed one of our Elf5 reporter lines (construct
#8 in which GFP is inserted into an Elf5 BAC) into Elf5-deﬁcient mice.
Fluorescence could be detected in construct 8 transgenic, Elf5−/−
embryos in the EPC region (Fig. 7B). We veriﬁed by whole mount in
situ hybridisation that this ﬂuorescence is not caused solely by the
long half life of the GFP protein (Figs. 7C, D). Thus functional Elf5 pro-
tein is not required for maintaining Elf5 expression.
Discussion
In mice, Elf5 expression is exclusive to the trophectoderm com-
partment from expanded (late) blastocyst to postgastrulation stages
(Donnison et al., 2005). While expressed predominantly in the ExE,
Elf5 expression also extends to the more proximal trophectoderm tis-
sue, the EPC, at E5.5 to E6.5. We have shown here that only the prox-
imal promoter of Elf5 is used for expression in the trophectoderm.
However, the promoter region and sequences upstream of it are in-
sufﬁcient to drive TE expression. The TE-speciﬁcity is provided by
two enhancers located in introns 1 and 2 respectively.
The Elf5 ExE-enhancers show distinguishing characteristics. First,
both enhancers always lead to mosaic expression. This feature is not
a technical artefact arising from late DNA incorporation during pro-
nuclear injection, as (F1) offspring from established mouse lines
also exhibited mosaicism. The mosaic expression is also seen in con-
structs containing both enhancers. Hence the individual enhancers
are not expressed in mutually exclusive subsets of cells that together
yield homogeneous expression in the ExE. The mosaicism increased
(that is, fewer cells were stained) when the B enhancer region was
trimmed down. This may be because as the number of functional, re-
dundant binding sites for transcription factors decreases, enhancer
activity drops below a minimally required threshold level. Therefore
C D E
E11 bElf5
sideview topview section
wt
mElf5 (#9)
E16 tail
B
wt
bElf5BAC
E17 tail
A
epi
hypo
TE
RL
emb. disc
emb. disc
Fig. 6. Lack of evolutionary conservation of Elf5 early embryonic expression. (A) Fluorescent microscopy of mouse tails of wild type and bovineElf5-DsRedBAC- transgenic foetuses.
(B) GFP expression in tails of foetuses transgenic for the 19 kbp two-enhancer containing construct 9. (C–E) Elf5 in situ hybridisation of E11 cattle embryos. Epi, epiblast; Hypo,
hypoblast (primitive endoderm); RL, Rauber's layer; TE, trophectoderm.
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centrations of the relevant transcription factors.
Second, both enhancers are dependent on the endogenous pro-
moter region and are unable to drive expression from the minimal
β-Globin promoter of pTrap. As a general rule, enhancers are capable
of activating transcription from heterologous promoters (Bulger and
Groudine, 2011). Enhancer–promoter speciﬁcity has been previously
seen to be mediated by DPE (downstream promoter element) versus
TATA box-containing core promoters (Butler and Kadonaga, 2001)
and/or via enhancer-speciﬁc ‘tethering’ elements found near some
promoters (Calhoun and Levine, 2003). Both the Elf5 proximal core
promoter and the β-Globin promoter contain a TATA-box, so tether-
ing elements within the 1.8 kbp promoter region are likely to account
for the unusual Elf5 enhancer-promoter speciﬁcity. The CpG-rich re-
gion (−970 to −260) is not necessary for such a tethering function,
as deletion of these sequences did not affect enhancer function.
Third, the two identiﬁed enhancers are not marked by high levels
of H3K4 monomethylation. Such an epigenetic signature has been
correlated with enhancer activity (Barski et al., 2007; Heintzman et
al., 2007; Rada-Iglesias et al., 2011). However, in these genome-
global Chip studies, only a subset of enhancers were examined, name-
ly those binding p300/CBP/BRG1. Whether this epigenetic signature
applies to all classes of enhancers is not clear (Bulger and Groudine,
2011) and our data indeed suggests that this is not the case.
The existence of two Elf5 enhancers driving ExE expression might
be explained by differential functions. However, both enhancers wereA B
Fig. 7. Elf5 does not maintain its own expression. (A) Whole mount in situ hybridisation (WM
in Elf5+/+ (wt) and Elf5−/− background. (C–D) WMISH of wt (C) and Elf5−/− (D) E6.5active between E5.5 and E7.5 and directed expression to the ExE as
well as the prospective EPC at E6.5. Furthermore, the enhancers re-
sembled each other in their properties as outlined previously. Thus
within the experimental conﬁnes of our assays, enhancers A and B
are redundant. Yet in spite of their functional similarity, sequence
comparisons yielded no signiﬁcant identity between the A and B en-
hancers. Searching for conservation of transcription factor binding
sites in the two enhancers using the enhancer-detection programme
EEL (Hallikas et al., 2006) with the JASPAR database (Sandelin et al.,
2004) identiﬁed many sites common to both sequences, but no con-
served clustering of such sites. It is thus likely that these enhancers
did not arise via a sequence duplication event but evolved indepen-
dently. Redundancy in enhancers may confer a selective advantage.
Seemingly redundant enhancers have been described for several
genes and recently shown, in Drosophila for Shavenbaby, to confer
phenotypic robustness in conditions of environmental and genetic
variability (Frankel et al., 2010).
The mouse-speciﬁc nature of the Elf5 ExE enhancers, as well as the
weak nature of the B-enhancer when cut down to a region of 1500 bp,
makes the experimental identiﬁcation of critical binding sites difﬁ-
cult. However, we can infer several characteristics regarding Elf5 reg-
ulation in the trophectoderm. Elf5 does not maintain its own
expression as seen by continued expression of the Elf5 reporter con-
structs in trophectoderm tissues after Elf5 deletion. As Elf5 mutants
lose the ExE as well as expression of genes such as Cdx2 and Eomeso-
dermin (Donnison et al., 2005), continued expression of Elf5 in theC D
ISH) of E6.5 embryo using an Elf5 probe. (B) GFP ﬂuorescence of construct 8 (Elf5-BAC)
construct 8-transgenic embryos with Gfp probe.
350 D.J. Pearton et al. / Developmental Biology 360 (2011) 343–350remaining TE tissue excludes these factors from an Elf5 transcription-
al maintenance role. Furthermore, sequence inspection of the two en-
hancer regions revealed no consensus Cdx2 binding sites whereas
Chip analyses (Nishiyama et al., 2009) only detected Cdx2 to bind
upstream of Elf5 in a region that we have shown here to have no
enhancer activity.
The lack of importance of the evolutionary-conserved region with-
in the minimal B-enhancer for ExE expression prompted our further
experiments using cattle Elf5 sequences. This led to the conclusion
that the mouse Elf5 trophectoderm enhancer is mouse speciﬁc. Cattle,
while transcribing Elf5 during early embryogenesis (Smith et al.,
2010) do so in the epiblast as opposed to the trophectoderm. During
later cattle embryogenesis (E17, 20 concepti at gastrulation/
neurulation stages and E26 post-implantation trophectoderm), Elf5
is undetectable (Smith et al., 2010). Hence while Elf5 is required
cell-autonomously for mouse trophectoderm (Donnison et al., 2005)
it is dispensable for cattle trophectoderm. Elf5 is necessary for main-
taining the ExE and trophoblast stem cells in the mouse. There would
appear to be no tissue clearly equivalent to the ExE in cattle. Thus the
unique deployment of Elf5 at early embryonic stages in the mouse re-
ﬂects fundamental differences in trophoblast development between
the two species. Regulatory differences have previously been seen
in cattle and mouse Oct4 which has been proposed to underlie the
delayed commitment of cattle trophectoderm (Berg et al., 2011). In
contrast to these differences, the onset of numerous other trophecto-
derm genes (Cdx2, Mash2, and Placental Lactogen) shows a similar
temporal onset of expression in cattle to mice (Smith et al., 2010).
Furthermore Cdx2, a gene crucial to mouse trophectoderm (Strumpf
et al., 2005) is also critical for cattle trophectoderm maintenance as
shown by RNAi-mediated knockdown (Berg et al., 2011). It appears
that while the overall gene regulatory network underlying trophecto-
derm development has been largely conserved, novel aspects have
been introduced presumably to accommodate species-speciﬁc re-
quirements. The rewiring of individual genes is not uncommon in
evolution and, if the affected gene is itself a masterswitch, may result
in the novel use of a gene regulatory network subcircuit (Peter and
Davidson, 2011). In the mammary gland, gain and loss of function ex-
periments demonstrated Elf5's role in the correct differentiation of a
speciﬁc cell population, the secretory alveolar cells (Oakes et al.,
2008). In the developing lung, overexpression studies implicated
Elf5 in preventing proximal lung epithelial cell differentiation
(Metzger et al., 2008). In these contexts Elf5 does function as a
“masterswitch”, even though we do not know the commonality in
the gene circuitry downstream of Elf5 that would have beneﬁted
the secondment of Elf5 to trophoblast development. A highly specula-
tive possibility is that Elf5 may be required to interpret FGF signalling:
In lung development, Elf5 is activated directly by FGF signalling
(Metzger et al., 2007) whereas FGF withdrawal in mouse trophoblast
stem cells leads to differentiation and reduced Elf5 levels (Donnison
et al., 2005). In marked contrast, cattle trophoblast stem-like cells
are not FGF dependent (Hashizume et al., 2006; Talbot et al., 2000)
nor do they require Elf5.
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